SAUDI ARABIA – King Faisal Specialist Hospital and Research Centre (KFSH&RC) has extended its memorandum of understanding with the Jameel Clinic, the epicenter of artificial intelligence (AI) in healthcare at the Massachusetts Institute of Technology (MIT).
Through the extended pact between the Jameel Clinic and KFSH&RC, Mira makes its debut as a promising tool for breast cancer detection in the Kingdom of Saudi Arabia.
Both parties will cooperate on the rollout of Mirai, a pioneering AI tool that can detect breast cancer up to five years earlier, and more accurately, than current mainstream screening techniques.
The joint statement said: “Mirai uses a non-invasive deep-learning algorithm to predict breast cancer using only a patient’s mammogram.”
Mirai was trained on the same dataset of over 200,000 exams from Massachusetts General Hospital (MGH) and was validated on test sets from MGH, the Karolinska Institute in Sweden, and Chang Gung Memorial Hospital (CGMH) in Taiwan.
This innovative tool is equally effective across different races and ethnicities worldwide, which presents a major advance for health equity.
Mirai is now installed at Massachusetts General Hospital, and the team’s collaborators are actively working on integrating the model into clinical care.
In July 2023, the Jameel Clinic at MIT and KFSH&RC entered into a partnership covering three key areas to drive forward the field of clinical AI.
The partnership seeks to enhance patient care, improve clinical outcomes, and reduce healthcare costs by developing and implementing advanced AI tools and solutions.
Commenting on this partnership, Dr. Osama Alswailem, Chief Information Officer at KFSH&RC, said: “Together, we aspire to pioneer cutting-edge solutions that effectively address healthcare needs, leading the way towards transformative advancements.”
Under the extended pact, the Jameel Clinic and KFSH&RC are set to deploy AI-enabled health technologies, with a focus on breast cancer care, to help save lives in the Kingdom of Saudi Arabia.
It is a clear reflection of the Jameel Clinic’s relentless efforts to develop AI technologies that will change the healthcare landscape.
Underlining the need to maximize the impact of clinical AI tools on patient lives, Professor Regina Barzilay, AI faculty lead at the Jameel Clinic, said: “Ensuring that the cutting-edge clinical AI research being done at MIT can be utilized in diverse clinical settings is critical to our mission at the Jameel Clinic.”
Building on MIT’s pioneering history in artificial intelligence and life sciences, the Jameel Clinic works on novel algorithms suitable for modeling biological and clinical data across a range of modalities including imaging, text, and genomics
The Jameel Clinic has collaborated with KFSH&RC in using artificial intelligence to deploy other innovative tools, including for the early detection of lung cancer.
These innovative tools are undergoing several tests on a wide range of patients under the supervision of specialist doctors to ensure that systematic health results are produced in a scientifically accurate manner.